OR WAIT null SECS
August 22, 2022
Grand River Aseptic Manufacturing has completed phase II of its facility expansion with the installation of two new sterile filling lines.
June 17, 2022
SCHOTT is planning to triple its ready-to-use vial production capacity in the United States to meet increasing demand for storing injectable drugs.
June 01, 2022
Demand spurs innovations in syringes and syringe fill/finish operations.
May 12, 2022
PCI Pharma Services is investing $100 million in manufacturing capabilities and capacity expansion to its Bedford, NH facility.
April 07, 2022
INCOG Biopharma has completed the construction of its cleanroom production area, marking a milestone in the completion of an overall $100 million investment in a new facility.
March 10, 2022
Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.
March 01, 2022
The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.
February 23, 2022
Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.
December 13, 2021
Fareva plans to use blow-fill-seal equipment and ApiJect’s prefilled injector technology to create fill/finish capacity in France.
November 01, 2021
Disposable equipment components find use in small-volume aseptic biopharmaceutical manufacturing.